Gamma-Dynacare Medical Laboratories acquires Maxxam Analytics’ Drug and Alcohol Testing

Gamma-Dynacare Medical Laboratories has acquired the drug and alcohol testing business of Maxxam Analytics, a leading provider of analytical services and solutions to the energy, environmental, food, and DNA industries. “This acquisition expands our toxicology business and establishes Gamma- Dynacare as the industry leader in the provision of drug and alcohol testing in Canada,” said Naseem Somani, President and Chief Executive Officer, Gamma- Dynacare Medical Laboratories. “We are expecting this important market to grow significantly over the next few years as more organizations adopt random testing programs to improve workplace and public safety as well as productivity.”